Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Microneedle Flu Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Microneedle Flu Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Microneedle Flu Vaccine Overall Market Size
2.1 Global Microneedle Flu Vaccine Market Size: 2021 VS 2028
2.2 Global Microneedle Flu Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Microneedle Flu Vaccine Sales: 2017-2028
3 Company Landscape
3.1 Top Microneedle Flu Vaccine Players in Global Market
3.2 Top Global Microneedle Flu Vaccine Companies Ranked by Revenue
3.3 Global Microneedle Flu Vaccine Revenue by Companies
3.4 Global Microneedle Flu Vaccine Sales by Companies
3.5 Global Microneedle Flu Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Microneedle Flu Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Microneedle Flu Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Microneedle Flu Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Microneedle Flu Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Microneedle Flu Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Microneedle Flu Vaccine Market Size Markets, 2021 & 2028
4.1.2 Solid Microneedle
4.1.3 Hollow Microneedle
4.1.4 Coated Microneedle
4.1.5 Dissolving Microneedle
4.2 By Type - Global Microneedle Flu Vaccine Revenue & Forecasts
4.2.1 By Type - Global Microneedle Flu Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Microneedle Flu Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Microneedle Flu Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Microneedle Flu Vaccine Sales & Forecasts
4.3.1 By Type - Global Microneedle Flu Vaccine Sales, 2017-2022
4.3.2 By Type - Global Microneedle Flu Vaccine Sales, 2023-2028
4.3.3 By Type - Global Microneedle Flu Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Microneedle Flu Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Microneedle Flu Vaccine Market Size, 2021 & 2028
5.1.2 Influenza A
5.1.3 Influenza B
5.2 By Application - Global Microneedle Flu Vaccine Revenue & Forecasts
5.2.1 By Application - Global Microneedle Flu Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Microneedle Flu Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Microneedle Flu Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Microneedle Flu Vaccine Sales & Forecasts
5.3.1 By Application - Global Microneedle Flu Vaccine Sales, 2017-2022
5.3.2 By Application - Global Microneedle Flu Vaccine Sales, 2023-2028
5.3.3 By Application - Global Microneedle Flu Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Microneedle Flu Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Microneedle Flu Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Microneedle Flu Vaccine Revenue & Forecasts
6.2.1 By Region - Global Microneedle Flu Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Microneedle Flu Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Microneedle Flu Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Microneedle Flu Vaccine Sales & Forecasts
6.3.1 By Region - Global Microneedle Flu Vaccine Sales, 2017-2022
6.3.2 By Region - Global Microneedle Flu Vaccine Sales, 2023-2028
6.3.3 By Region - Global Microneedle Flu Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Microneedle Flu Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Microneedle Flu Vaccine Sales, 2017-2028
6.4.3 US Microneedle Flu Vaccine Market Size, 2017-2028
6.4.4 Canada Microneedle Flu Vaccine Market Size, 2017-2028
6.4.5 Mexico Microneedle Flu Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Microneedle Flu Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Microneedle Flu Vaccine Sales, 2017-2028
6.5.3 Germany Microneedle Flu Vaccine Market Size, 2017-2028
6.5.4 France Microneedle Flu Vaccine Market Size, 2017-2028
6.5.5 U.K. Microneedle Flu Vaccine Market Size, 2017-2028
6.5.6 Italy Microneedle Flu Vaccine Market Size, 2017-2028
6.5.7 Russia Microneedle Flu Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Microneedle Flu Vaccine Market Size, 2017-2028
6.5.9 Benelux Microneedle Flu Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Microneedle Flu Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Microneedle Flu Vaccine Sales, 2017-2028
6.6.3 China Microneedle Flu Vaccine Market Size, 2017-2028
6.6.4 Japan Microneedle Flu Vaccine Market Size, 2017-2028
6.6.5 South Korea Microneedle Flu Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Microneedle Flu Vaccine Market Size, 2017-2028
6.6.7 India Microneedle Flu Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Microneedle Flu Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Microneedle Flu Vaccine Sales, 2017-2028
6.7.3 Brazil Microneedle Flu Vaccine Market Size, 2017-2028
6.7.4 Argentina Microneedle Flu Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Microneedle Flu Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Microneedle Flu Vaccine Sales, 2017-2028
6.8.3 Turkey Microneedle Flu Vaccine Market Size, 2017-2028
6.8.4 Israel Microneedle Flu Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Microneedle Flu Vaccine Market Size, 2017-2028
6.8.6 UAE Microneedle Flu Vaccine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Corporate Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Microneedle Flu Vaccine Major Product Offerings
7.1.4 Sanofi Microneedle Flu Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Sanofi Key News
7.2 GC Pharma
7.2.1 GC Pharma Corporate Summary
7.2.2 GC Pharma Business Overview
7.2.3 GC Pharma Microneedle Flu Vaccine Major Product Offerings
7.2.4 GC Pharma Microneedle Flu Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 GC Pharma Key News
7.3 Debiotech
7.3.1 Debiotech Corporate Summary
7.3.2 Debiotech Business Overview
7.3.3 Debiotech Microneedle Flu Vaccine Major Product Offerings
7.3.4 Debiotech Microneedle Flu Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Debiotech Key News
7.4 NanoPass Technologies
7.4.1 NanoPass Technologies Corporate Summary
7.4.2 NanoPass Technologies Business Overview
7.4.3 NanoPass Technologies Microneedle Flu Vaccine Major Product Offerings
7.4.4 NanoPass Technologies Microneedle Flu Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 NanoPass Technologies Key News
7.5 Corium International
7.5.1 Corium International Corporate Summary
7.5.2 Corium International Business Overview
7.5.3 Corium International Microneedle Flu Vaccine Major Product Offerings
7.5.4 Corium International Microneedle Flu Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Corium International Key News
7.6 Becton Dickinson and Company
7.6.1 Becton Dickinson and Company Corporate Summary
7.6.2 Becton Dickinson and Company Business Overview
7.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Major Product Offerings
7.6.4 Becton Dickinson and Company Microneedle Flu Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Becton Dickinson and Company Key News
7.7 FluGen
7.7.1 FluGen Corporate Summary
7.7.2 FluGen Business Overview
7.7.3 FluGen Microneedle Flu Vaccine Major Product Offerings
7.7.4 FluGen Microneedle Flu Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 FluGen Key News
7.8 CosMED Pharmaceuticals
7.8.1 CosMED Pharmaceuticals Corporate Summary
7.8.2 CosMED Pharmaceuticals Business Overview
7.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Major Product Offerings
7.8.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 CosMED Pharmaceuticals Key News
7.9 Microdermics and OraSure Technologies
7.9.1 Microdermics and OraSure Technologies Corporate Summary
7.9.2 Microdermics and OraSure Technologies Business Overview
7.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Major Product Offerings
7.9.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Microdermics and OraSure Technologies Key News
8 Global Microneedle Flu Vaccine Production Capacity, Analysis
8.1 Global Microneedle Flu Vaccine Production Capacity, 2017-2028
8.2 Microneedle Flu Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Microneedle Flu Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Microneedle Flu Vaccine Supply Chain Analysis
10.1 Microneedle Flu Vaccine Industry Value Chain
10.2 Microneedle Flu Vaccine Upstream Market
10.3 Microneedle Flu Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Microneedle Flu Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer